You will need to login before you can apply for a job.
Executive Director - Oncology Early Development Leader
View more categories View less categories Sector Health and Medical Role Executive Contract Type Permanent Hours Full Time
Site Name: USA - Pennsylvania - Upper Providence, GSK HQ, Switzerland - Zug, UK - Hertfordshire - Stevenage, USA - Massachusetts - Waltham, Warsaw Rzymowskiego 53
Posted Date: Dec 10 2024
Are you energized by a scientific leadership opportunity that allows you to develop medicines and shape the scientific program for a growing oncology pipeline? If so, this Executive Director - Oncology Early Development Leader position could be an ideal opportunity to explore.
The Early Development Leader (EDL) is a critical role within GSK R&D Oncology which reports to the VP EDLs. The EDL is the single point of accountability to strategically lead the development of a medicine between Candidate Selection (CS) and through Proof of Concept, substantially contributing to defining the early development strategy for an asset. By working with various stakeholders across R&D, Commercial and Manufacturing, they obtain and manage associated resources, and deliver evidence in line with the strategic vision and organizational strategy to support progression beyond early development for a clearly differentiated medicine.
You'll play a critical role in the development of GSK's Oncology pipeline, guiding products through the development process and making a genuine personal impact on the GSK, and wider, oncology therapy area. Additionally, through the successful delivery of this role you will build a fantastic internal and external network, and a position as an industry leading authority in Oncology R&D.
Key Responsibilities:
* Strategic leadership and single point of accountability for the development of an asset or portfolio of assets within R&D, from candidate selection through Proof of Concept.
* Contributing to and establishing the development strategy aligned with Medicine Profile (MP) with input and alignment from late stage development, franchise commercial, and medical.
* Makes clear evidence-based go / no go / accelerate decisions, based on whether the results fulfil the strategy set out for the medicine, and identify clear inflection points.
* Identifies and engages the external community appropriately in robust scientific dialogue that generates insight and advances scientific and medical understanding.
* Ensures timely and appropriate interaction and exchange of information between GSK and external communities (e.g., patients, physicians, payers, regulators), in strict adherence with GSK Policies, and GSK Global Scientific Engagement Principles and Standards.
* Ensures balanced and robust scientific communications in all formats.
* Proactively identifies unique regulatory requirements that are necessary for the development of early stage development e.g. introduction of first dosing in patient populations, clinical pharmacology and metabolism.
* Anticipates the changing healthcare & competitive environment and delivers innovative strategies and plans to generate evidence for relevant pharmacology/efficacy and prescribing/usage within this environment.
* Understands the impact of new data on the value/positioning of products in guidelines/formularies.
* When necessary in early stage, partners with Business Development to facilitate diligence reviews, product positioning and/or alternative business strategies (e.g., public private partnerships, co-development) and internal review and decision-making processes in line with GSK governance procedures as well as use of appropriate alliance management mechanisms to ensure successful business transactions and relationships.
* Models GSK values and leadership expectations.
Why You?
Basic Qualifications:
* Experience in oncology clinical development, including early stage oncology and its connections with late stage development.
* Has the ability to translate pre-clinical data to develop an oncology clinical development program.
* Has managed and developed individuals and teams in a matrix environment.
* Experience of working across preclinical medicine development, translational medicine, including experimental medicine design and its application.
* End to end clinical development exposure and accountability for all aspects of the strategic planning through to PoC which enables progression beyond PoC.
Preferred Qualifications:
* Advanced degree such as MD, PhD, or PharmD, or equivalent is highly preferable.
* Three (3) or more years' experience leading oncology development programs with experience fulfilling requirements of regulatory filings to initiate clinical testing (e.g. IND).
* Experience leading or participating in Business Development/Due Diligence activities.
* Experience leading or participating in late stage (Phase 3) clinical development program.
* Experience leading or participating in commercial product launch activities.
GSK is a global biopharma company with a special purpose - to unite science, technology and talent to get ahead of disease together - so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns - as an organisation where people can thrive.
We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology, and oncology).
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it's also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged, and challenged to be the best they can be. A place where they can be themselves - feeling welcome, valued, and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.
GSK is an Equal Opportunity Employer and, in the US, we adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.
#J-18808-Ljbffr